Digital pathology is defined as an image-based information setting enabled by computer technology that allows the management of information generated through a digital slide. Digitalization of pathology has led to the automation of tests during diagnosis. For example, a single digital instrument can perform tests that were previously carried out using five instruments by pathologists. Research Beam Model: Research Beam Product ID: 925271 5370 USD New
Germany Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication and Telepathology), End User (Educational Institutes, Hospitals and Diagnostic Centers and Pharmaceutical and Biotechnology Companies) - Opportunity Analysis and Industry Forecast, 2014-2022
 
 

Germany Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication and Telepathology), End User (Educational Institutes, Hospitals and Diagnostic Centers and Pharmaceutical and Biotechnology Companies) - Opportunity Analysis and Industry Forecast, 2014-2022

  • Category : Medical Devices
  • Published On : September   2016
  • Pages : 91
  • Publisher : Allied Market Research
 
 
 

Digital pathology is defined as an image-based information setting enabled by computer technology that allows the management of information generated through a digital slide. Digitalization of pathology has led to the automation of tests during diagnosis. For example, a single digital instrument can perform tests that were previously carried out using five instruments by pathologists. Digital pathology solutions offer a scrutiny & analysis of images on a computer, high-resolution sample scanning, and online storage of digital slides, which enable pathologists to cross examine slides without physical evidences.

The German digital pathology market is projected to garner revenue worth $58 million by 2022, registering a CAGR of 12.1% over the forecast period. The growth of the market is attributed to factors such as efficient cost of digital pathology products, ease of virtual transportation of slides, high efficiency of digital pathology systems, and more efficiency. In addition, higher adoption of digital pathology over conventional pathology treatments further drives the world market. On the other hand, barriers such as lack of reimbursement, lack of skilled personnel, and unwillingness of older pathologists to adopt to new technology are some of the major factors expected to restrain the market growth. However, rise in initiatives towards commercialization of cost-efficient digital pathology systems would offer profitable growth opportunities for service providers in the future.

The German digital pathology market is segmented on the basis of product and end users. Based on product, the market is classified into Whole Slide Imaging (WSI), image analysis informatics, information management system storage & communication, and telepathology. Whole slide imaging is the highest revenue-generating segment as it is the most preferred method and is used to produce digital slides by scanning the whole glass slide. Similarly, by end user, the market is segmented into educational institutes, hospitals & diagnostic centers, and pharma & biotechnology companies.

Companies have adopted product launch and collaboration as their key development strategies. Increase in focus on product launch is mainly for the development of innovative technologies in the field of digital pathology. In March 2016, Definiens launched “Immunoprofiling Panel” to screen their target biomarkers and measure immune response, thereby expanding its product portfolio.

KEY BENEFITS FOR STAKEHOLDERS:

  • In-depth analysis is carried out based on market estimations of the key segments from 2014 to 2022.
  • The report provides comprehensive analysis of factors that drive and restrict the growth of the German digital pathology market.
  • Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework.
  • The report also provides quantitative as well as qualitative market trends to assist the stakeholders understand the situations prevailing in the market.
  • Competitive analysis of key players is conducted to help stakeholders to understand the inherent trends followed by their competitors and make the necessary amendments to the existing expansion plans

KEY MARKET SEGMENTS:

By Product

  • Whole Slide Imaging
  • Image Analysis Informatics
  • Information Management System Storage & Communication
  • Telepathology

By End User

  • Educational Institutes
  • Hospitals and Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies

Key players operating in the market include:

  • Visiopharm
  • Digipath Inc.
  • Koninklinje Philips N. V.
  • PerkinElmer, Inc.
  • Danaher Corporation (Leica Microsystem)
  • Nikon Corporation
  • Carl Zeiss AG
  • Definiens AG
  • VMscope GmbH
  • microDimensions GmbH

Other players in the value chain include:

  • Indica Labs
  • Hamamatsu Photonics Europe GmbH
  • Pixcelldata Ltd.
  • Glencoe Software Inc.
  • *Profiles of these players are not included. The same will be included on request

CHAPTER 1 INTRODUCTION

1.1 Report description
1.1 Key benefits
1.2 Key market segment
1.3 Research methodology

1.3.1 Secondary research
1.3.2 Primary research
1.3.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top winning strategies

3.3 Conventional pathology vs. digital pathology
3.4 Key player positioning, 2015
3.5 Market dynamics

3.5.1 Drivers

3.5.1.1 Use of digital pathology in cancer diagnosis
3.5.1.2 Cost efficiency
3.5.1.3 Ease in transportation
3.5.1.4 High efficiency
3.5.1.5 Efficient analysis
3.5.1.6 System efficiency
3.5.1.7 Efficiency in workflow
3.5.1.8 Diagnosis in remote regions

3.5.2 Restraints

3.5.2.1 Lack of reimbursement
3.5.2.2 Lack of infrastructure in developing economies
3.5.2.3 Resistance towards adoption of digital pathology

3.5.3 Opportunities

3.5.3.1 Rising awareness pertaining to digital pathology
3.5.3.2 Increasing potential of digital pathology

CHAPTER 4 GERMANY DIGITAL PATHOLOGY MARKET, BY PRODUCT

4.1 Overview

4.1.1 Market size and forecast
4.1.2 Whole slide imaging (WSI)

4.1.2.1 Market size and forecast

4.1.3 Image analysis informatics

4.1.3.1 Market size and forecast

4.1.4 Information management system storage & communication

4.1.4.1 Market size and forecast

4.1.5 Telepathology

4.1.5.1 Market size and forecast

CHAPTER 5 GERMANY DIGITAL PATHOLOGY MARKET, BY END USER

5.1 Overview

5.1.1 Market size and forecast
5.1.2 Educational institutes

5.1.2.1 Market size and forecast

5.1.3 Hospitals and diagnostic centers

5.1.3.1 Market size and forecast

5.1.4 Pharmaceutical and biotechnology companies

5.1.4.1 Market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1 Danaher Corporation (Leica Microsystem)

6.1.1 Company Overview
6.1.2 Company Snapshot
6.1.3 Operating Business Segments
6.1.4 Business Performance
6.1.5 Key Strategic Moves & Developments

6.2 Definiens AG

6.2.1 Company Overview
6.2.2 Company Snapshot
6.2.3 Business Performance
6.2.4 Key Strategic Moves & Developments

6.3 Carl Zeiss AG

6.3.1 Company Overview
6.3.2 Company Snapshot
6.3.3 Operating Business Segments
6.3.4 Business Performance
6.3.5 Key Strategic Moves and Developments

6.4 VMscope GmbH

6.4.1 Company Overview
6.4.2 Company Snapshot
6.4.3 Operating Business Segments
6.4.4 Business Performance
6.4.5 Key Strategic Moves and Developments

6.5 microDimensions GmbH

6.5.1 Company Overview
6.5.2 Company Snapshot
6.5.3 Operating Business Segments
6.5.4 Business Performance
6.5.5 Key Strategic Moves and Developments

6.6 Visiopharm

6.6.1 Company Overview
6.6.2 Company Snapshot
6.6.3 Operating Business Segments
6.6.4 Business Performance
6.6.5 Key Strategic Moves & Developments

6.7 Koninklijke Philips N.V.

6.7.1 Company Overview
6.7.2 Company Snapshot
6.7.3 Operating Business Segments
6.7.4 Business Performance
6.7.5 Key Strategic Moves & Developments

6.8 PerkinElmer, Inc.

6.8.1 Company Overview
6.8.2 Company Snapshot
6.8.3 Operating Business Segments
6.8.4 Business Performance
6.8.5 Key Strategic Moves & Developments

6.9 Nikon Corporation

6.9.1 Company Overview
6.9.2 Company Snapshot
6.9.3 Operating Business Segments
6.9.4 Business Performance
6.9.5 Key Strategic Moves & Developments

6.10 Digipath, Inc.

6.10.1 Company Overview
6.10.2 Company Snapshot
6.10.3 Operating Business Segments
6.10.4 Key Strategic Moves & Developments

Other players in the value chain include:

  • Indica Labs
  • Hamamatsu Photonics Europe GmbH
  • Pixcelldata Ltd.
  • Glencoe Software Inc.

*Profiles of these players are not included. The same will be included on request.

List of Figures

FIG. 1 DATA TRIANGULATION METHODOLOGY
FIG. 2 PRIMARY AND SECONDARY RESEARCH
FIG. 3 INDUSTRY PARTICIPANTS FROM SUPPLY SIDE
FIG. 4 INDUSTRY PARTICIPANTS FROM DEMAND SIDE
FIG. 5 GERMANY DIGITAL PATHOLOGY MARKET, 2015 VS 2022, ($MILLION)
FIG. 6 DIGITAL PATHOLOGY: MARKET DEFINITION
FIG. 7 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION
FIG. 8 TYPES OF STRATEGIES DISTRIBUTION
FIG. 9 DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIG. 10 KEY PLAYER POSITIONING, 2015
FIG. 11 TOP IMPACTING FACTORS: GERMANY DIGITAL PATHOLOGY MARKET (20142022)
FIG. 12 DIGITAL PATHOLOGY: WORKFLOW
FIG. 13 GERMANY: WHOLE SLIDE IMAGING MARKET, 20142022 ($MILLION)
FIG. 14 GERMANY: IMAGE ANALYSIS INFORMATICS MARKET, 20142022 ($MILLION)
FIG. 15 INFORMATION MANAGEMENT SYSTEM STORAGE & COMMUNICATION: STORAGE WORKFLOW
FIG. 16 GERMANY: INFORMATION MANAGEMENT SYSTEM STORAGE & COMMUNICATION MARKET, 20142022 ($MILLION)
FIG. 17 GERMANY: TELEPATHOLOGY MARKET, 20142022 ($MILLION)
FIG. 18 GERMANY: EDUCATIONAL INSTITUTES END USER MARKET, 20142022 ($MILLION)
FIG. 19 GERMANY: HOSPITALS AND DIAGNOSTIC END USER MARKET, 20142022 ($MILLION)
FIG. 20 GERMANY: PHARMACEUTICAL & BIOTECHNOLOGY END USER MARKET, 20142022 ($MILLION)
FIG. 21 DANAHER: NET SALES, 20132015 ($MILLION)
FIG. 22 DANAHER: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 23 DANAHER: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 24 DANAHER: STRATEGY SHARE, 20122015 (%)
FIG. 25 DEFINIENS: STRATEGY SHARE, 20142016 (%)
FIG. 26 CARL ZEISS: REVENUE, 20132015 ($MILLION)
FIG. 27 CARL ZEISS: REVENUE, BY SEGMENT, 2015 (%)
FIG. 28 CARL ZEISS: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 29 CARL ZEISS: STRATEGY SHARE, 2016 (%)
FIG. 30 VMSCOPE: STRATEGY SHARE, 20132015 (%)
FIG. 31 VISIOPHARM: STRATEGY SHARE, 20142016 (%)
FIG. 32 PHILIPS HEALTHCARE: NET SALES, 20132015 ($MILLION)
FIG. 33 PHILIPS HEALTHCARE: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 34 KONINKLIJKE PHILIPS N. V.: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 35 PHILIPS HEALTHCARE: STRATEGY SHARE, 20142016 (%)
FIG. 36 PERKINELMER, INC.: NET SALES, 20132015 ($MILLION)
FIG. 37 PERKINELMER INC.: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 38 PERKINELMER INC.: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 39 PERKINELMER INC.: STRATEGY SHARE, 20142016 (%)
FIG. 40 NIKON: NET SALES, 20132015 ($MILLION)
FIG. 41 NIKON: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 42 NIKON: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 43 DIGIPATH: STRATEGY SHARE, 20132014 (%)

List of Table

TABLE 1 GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20142022 ($MILLION)
TABLE 2 GERMANY: WHOLE SLIDE IMAGING MARKET, 20142022 ($MILLION)
TABLE 3 GERMANY: IMAGE ANALYSIS INFORMATICS MARKET, 20142022 ($MILLION)
TABLE 4 GERMANY: INFORMATION MANAGEMENT SYSTEM STORAGE & COMMUNICATION MARKET, 20142022 ($MILLION)
TABLE 5 GERMANY: TELEPATHOLOGY MARKET, 20142022 ($MILLION)
TABLE 6 GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER, 20142022 ($MILLION)
TABLE 7 GERMANY: EDUCATIONAL INSTITUTES END USER MARKET, 20142022 ($MILLION)
TABLE 8 GERMANY: HOSPITALS & DIAGNOSTIC CENTERS END USER MARKET, 20142022 ($MILLION)
TABLE 9 GERMANY: PHARMACEUTICAL & BIOTECHNOLOGY END USER MARKET, 20142022 ($MILLION)
TABLE 10 DANAHER: COMPANY SNAPSHOT
TABLE 11 DANAHER: OPERATING SEGMENTS
TABLE 12 DEFINIENS: COMPANY SNAPSHOT
TABLE 13 CARL ZEISS: COMPANY SNAPSHOT
TABLE 14 CARL ZEISS: OPERATING SEMENTS
TABLE 15 VMSCOPE: COMPANY SNAPSHOT
TABLE 16 VMSCOPE: OPERATING SEGMENT
TABLE 17 MICRODIMENSIONS GMBH: COMPANY SNAPSHOT
TABLE 18 MICRODIMENSIONS: OPERATING SEGMENT
TABLE 19 VISIOPHARM: COMPANY SNAPSHOT
TABLE 20 VISIOPHARM: OPERATING SEGMENTS
TABLE 21 KONINKLIJKE PHILIPS N. V.: COMPANY SNAPSHOT
TABLE 22 PHILIPS HEALTHCARE: OPERATING SEGMENTS
TABLE 23 PERKINELMER INC.: COMPANY SNAPSHOT
TABLE 24 PERKINELMER INC.: OPERATING SEGMENTS
TABLE 25 NIKON: COMPANY SNAPSHOT
TABLE 26 NIKON: OPERATING SEGMENTS
TABLE 27 DIGIPATH, INC: COMPANY SNAPSHOT
TABLE 28 DIGIPATH: OPERATIN

PURCHASE OPTIONS
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT